By utilizing specifically designed antisense oligonucleotides and AAV9-mediated delivery to induce skipping of both exon 5 and exon 6 of MYBPC3, the study successfully reversed cardiac dysfunction and inhibited left ventricular hypertrophy in the mice. This evidence concerns the gene MYBPC3 and left ventricular hypertrophy.